Story thread · 2 reports / 1 sources
Lexaria Bioscience advances 12% on Australian tax rebate
seekingalpha.com · 13d
First report: Lexaria receives $2.6M R&D tax rebate from Australian Tax Office; shares up over 14% — seekingalpha.com, 13d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.